Hepatocellular Tumorigenicity of Butylated Hydroxytoluene Administered Orally to B6C3F1 Mice

48Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Butylated hydroxytoluene (BHT), a preservative widely found in food as a food additive, was orally administered at concentrations of 1% and 2% of the diet to B6C3F1 mice for 104 consecutive weeks. Treated animals underwent a 16‐week recovery period prior to pathological examination. In male mice administered BHT, the incidence of mice with either a hepatocellular adenoma or a focus of cellular alteration in the liver was increased in a clear dose‐response relationship. The incidences of male mice with other tumors and the incidences of female mice with any tumor were not significantly increased as a consequence of BHT administration. The results of this study indicate BHT to be tumorigenic to the liver of the B6C3F1 male mouse. Copyright © 1988, Wiley Blackwell. All rights reserved

Author supplied keywords

Cite

CITATION STYLE

APA

Inai, K., Kobuke, T., Nambu, S., Takemoto, T., Kou, E., Nishina, H., … Tokuoka, S. (1988). Hepatocellular Tumorigenicity of Butylated Hydroxytoluene Administered Orally to B6C3F1 Mice. Japanese Journal of Cancer Research, 79(1), 49–58. https://doi.org/10.1111/j.1349-7006.1988.tb00010.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free